Effective Scenario Planning for Drug Development: A Conversation With Experts

Register free: http://www.appliedclinicaltrialsonline.com/act_w/innovative_strategies

Event overview:

As competition in the biopharmaceutical industry increases, firms must make effective drug development trade-off decisions considering risk, timing and cost. This requires collaboration across functions, informed forecasts, and, ideally, comparison of multiple options.

Please join us for a webinar discussing these trade-offs and how companies can work in a cross-functional way to achieve effective scenario planning. Learn about the common dynamics that development teams need to evaluate, and how to build scenario comparisons to choose the best path forward. Hear from drug development experts about the different types of trade-offs in clinical development planning, and how to use real-world evidence and adaptive trial designs to supercharge decision-making. We will also showcase a technology platform for optimizing clinical development scenario planning.

Key Learning:

• Innovative clinical development strategies combined with real-world data can improve your organization’s decision-making
• Different experts and teams optimize their development plans using scenario planning and analytics
• Pipeline Architect, a data-driven web tool, improves and drives decision-making

Speakers Name and Title:

Rick Johnston, PhD
Senior Software Solutions Lead
IQVIA

Dr. Johnston is the Senior Software Solutions Lead within IQVIA's Consulting Organization. He is an accomplished technical leader with more than 15 years’ experience in building software that solves big data, machine learning and advanced analytics problems in pharma. Software built by Dr. Johnston is used by more than 90% of the world’s 25 largest pharmaceutical companies. He has a Ph.D. in operations research and bioinformatics from UC Berkeley.

David Wolter
VP, Consulting Services
IQVIA

David Wolter is a Vice President of IQVIA’s Consulting Services group. He has more than 15 years of experience in management consulting and modeling system development and is the lead of the US Strategy & Portfolio Analysis Solution Team. His past work has included product valuations, detailed forecasting exercises, analogue analyses, and decision-analysis/strategy projects – both with and without the support of software tools. David has an MBA from Stanford GSB, an MS in Accounting from DePaul University and a BA in Economics from Amherst College.

Times and Date:

On-Demand

Sponsor:

IQVIA

Register free: http://www.appliedclinicaltrialsonline.com/act_w/innovative_strategies